Sequanta Technologies is a leading multi-omics research and clinical service provider in China, focusing on genomics, proteomics and related services to support pharmaceutical clients in biomarker discovery and clinical trials. Sequanta provides diversified genomics and proteomics assays validated by research standard and CAP standard, which include genotyping and gene expression qPCR assays, NGS assays and protein biomarker detection assays. The featured assays include Foundation One CDx, Illumina TSO500 assay for tissue and ctDNA, Single cell solutions, Olink Flex, Target 48/96 and Explore 384/3072 assays, whole genome and whole exome sequencing, meta-genome , mRNA and smRNA sequencing, , etc. Customized panels are also available based on specific project needs.